We offer comprehensive development services for New Chemical Entities (NCEs), generics, and phytopharmaceuticals. Our expertise helps you navigate the regulatory path for IND/CTA/ANDA/NDA applications.

Formulations

• Pre-formulation profiling and druggability assessment
• Generic formulation development for parenteral, solid-liquid oral products to support ANDA (NCE 1 /P IV/PIII/PII certifications) applications
• Development of drug product to support NDA 505 b2) applications
• Pediatric Formulation Development
• Drug product development for Phytopharmaceuticals
• Preclinical formulation development
• NCE formulation development for FIH (First in Human) and various clinical phases
• Veterinary formulation development 

Dosage Form Capabilities

• Solid Orals: Capsules and Tablets with different release profiles (immediate release, delayed release, extended release, sustained release), Effervescent tablets, Chewable tablets, Dispersible tablets, Orally dispersible tablets (ODT), Mouth dissolving tablets, Sub-lingual tablets, Pellets with different release profiles, Pellets into tablets, Bilayer tablets, Mini-tablets in capsules, Liquid-filled capsules.
• Liquid Orals: Ready-to-use solution, Ready-to-use suspension, Powder for solution, Powder for suspension, Sachets, Emulsions, SEDDs
• Parenteral: Solutions, Lyophilized products, Peptide injectables, Depot injectables, Ophthalmic formulation, solution for inhalation/nebulization, emulsions, Vials /Ampoules / Pre-filled-Syringes
• Medical Devices: NPD of Class I, IIA & IIB

Process capabilities

• Dry Granulation
• High shear wet granulation
• Fluid bed granulation
• Direct compression
• Fluid bed drying
• Milling
• Compression
• Tablet coating
• Encapsulation
• Air jet milling (actives)
• Palletisation
• Lyophilisation